Abeona Therapeutics (ABEO)
5.45
+0.07 (1.30%)
Upcoming Events
Latest Headlines
Form 144 ABEONA THERAPEUTICS INC. Filed by: Vasanthavada Madhav
June 8, 2026 6:40 PM - SEC Filing
Form 144 ABEONA THERAPEUTICS INC. Filed by: O'Malley Brendan M.
June 8, 2026 6:39 PM - SEC Filing
Form 144 ABEONA THERAPEUTICS INC. Filed by: Seshadri Vishwas
June 8, 2026 6:39 PM - SEC Filing
Form 144 ABEONA THERAPEUTICS INC. Filed by: Vazzano Joseph Walter
June 8, 2026 6:38 PM - SEC Filing
Form 8-K ABEONA THERAPEUTICS INC. For: Jun 03
June 4, 2026 7:31 AM - SEC Filing
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 1, 2026 8:30 AM - StreetInsider
Form 4 ABEONA THERAPEUTICS INC. For: May 26 Filed by: Alvino Mark
May 26, 2026 4:41 PM - SEC Filing
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
May 26, 2026 8:30 AM - StreetInsider
Form 4 ABEONA THERAPEUTICS INC. For: May 22 Filed by: Alvino Mark
May 22, 2026 5:24 PM - SEC Filing
Form 144 ABEONA THERAPEUTICS INC. Filed by: Alvino Mark
May 22, 2026 4:12 PM - SEC Filing
Form 4 ABEONA THERAPEUTICS INC. For: May 15 Filed by: Crombez Eric
May 15, 2026 5:01 PM - SEC Filing
Form SCHEDULE 13G/A ABEONA THERAPEUTICS INC. Filed by: Nantahala Capital Management, LLC
May 15, 2026 4:49 PM - SEC Filing
Form SCHEDULE 13G/A ABEONA THERAPEUTICS INC. Filed by: Nantahala Capital Partners Limited Partnership
May 15, 2026 4:41 PM - SEC Filing
Form 144 ABEONA THERAPEUTICS INC. Filed by: Crombez Eric
May 15, 2026 4:32 PM - SEC Filing
Form 10-Q ABEONA THERAPEUTICS INC. For: Mar 31
May 13, 2026 7:36 AM - SEC Filing
Abeona Therapeutics (ABEO) Tops Q1 EPS by 4c
May 13, 2026 7:32 AM - StreetInsider
Form 8-K ABEONA THERAPEUTICS INC. For: May 13
May 13, 2026 7:31 AM - SEC Filing
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
May 13, 2026 7:30 AM - Globe NewsWire
Form 4 ABEONA THERAPEUTICS INC. For: May 11 Filed by: Vasanthavada Madhav
May 11, 2026 6:37 PM - SEC Filing
Form 144 ABEONA THERAPEUTICS INC. Filed by: Vasanthavada Madhav
May 11, 2026 4:18 PM - SEC Filing
Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®
May 11, 2026 8:42 AM - StreetInsider
Abeona adds Children's Hospital of Philadelphia for ZEVASKYN treatment
May 11, 2026 8:30 AM - StreetInsider
Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®
May 11, 2026 8:30 AM - Globe NewsWire
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 5, 2026 9:26 AM - StreetInsider
Form DEFA14A ABEONA THERAPEUTICS INC.
May 4, 2026 4:55 PM - SEC Filing
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 4, 2026 10:50 AM - Globe NewsWire
Abeona Therapeutics® Announces Date of First Quarter Financial Results
May 4, 2026 8:30 AM - Globe NewsWire
Form SCHEDULE 13G ABEONA THERAPEUTICS INC. Filed by: HIRSCHMAN ORIN
April 28, 2026 4:17 PM - SEC Filing
Form ARS ABEONA THERAPEUTICS INC. For: Dec 31
April 27, 2026 4:32 PM - SEC Filing
Form DEF 14A ABEONA THERAPEUTICS INC. For: Apr 27
April 27, 2026 4:31 PM - SEC Filing
Form PRE 14A ABEONA THERAPEUTICS INC. For: Apr 17
April 17, 2026 4:31 PM - SEC Filing
Form 4 ABEONA THERAPEUTICS INC. For: Apr 01 Filed by: Goldan Keith A.
April 7, 2026 12:55 PM - SEC Filing
Form 3 ABEONA THERAPEUTICS INC. For: Apr 01 Filed by: Goldan Keith A.
April 7, 2026 12:55 PM - SEC Filing
Form 8-K ABEONA THERAPEUTICS INC. For: Apr 01
April 7, 2026 12:54 PM - SEC Filing
Abeona Therapeutics names Keith Goldan to board of directors
April 7, 2026 12:47 PM - StreetInsider
Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors
April 7, 2026 12:47 PM - Globe NewsWire
Abeona Therapeutics appoints Keith Goldan to board of directors
April 7, 2026 8:42 AM - StreetInsider
Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors
April 7, 2026 8:41 AM - StreetInsider
Form SCHEDULE 13G ABEONA THERAPEUTICS INC. Filed by: Funicular Funds, LP
April 6, 2026 6:01 PM - SEC Filing
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 6, 2026 8:30 AM - StreetInsider
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York
April 2, 2026 8:30 AM - Globe NewsWire
Form 4 ABEONA THERAPEUTICS INC. For: Mar 31 Filed by: Seshadri Vishwas
March 31, 2026 9:04 PM - SEC Filing
Form 144 ABEONA THERAPEUTICS INC. Filed by: Seshadri Vishwas
March 31, 2026 4:43 PM - SEC Filing
Form SCHEDULE 13G ABEONA THERAPEUTICS INC. Filed by: Kaufman Daniel Louis
March 27, 2026 2:49 PM - SEC Filing
Form SCHEDULE 13G/A ABEONA THERAPEUTICS INC. Filed by: VANGUARD GROUP INC
March 26, 2026 9:04 AM - SEC Filing
Form 8-K ABEONA THERAPEUTICS INC. For: Mar 16
March 20, 2026 4:32 PM - SEC Filing
Oppenheimer Reiterates Outperform Rating on Abeona Therapeutics (ABEO) following earnings
March 17, 2026 5:10 PM - StreetInsider
Abeona Therapeutics (ABEO) PT Lowered to $17 at Stifel on Zevaskyn sales estimates
March 17, 2026 3:53 PM - StreetInsider
Form 10-K ABEONA THERAPEUTICS INC. For: Dec 31
March 17, 2026 7:36 AM - SEC Filing
Form 8-K ABEONA THERAPEUTICS INC. For: Mar 17
March 17, 2026 7:30 AM - SEC Filing
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
March 17, 2026 7:30 AM - StreetInsider
Form 144 ABEONA THERAPEUTICS INC. Filed by: Vazzano Joseph Walter
March 16, 2026 4:32 PM - SEC Filing
Form 4 ABEONA THERAPEUTICS INC. For: Mar 16 Filed by: Vazzano Joseph Walter
March 16, 2026 4:30 PM - SEC Filing
Full Article List
